TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints November 10, 1989
TCL Archive NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive” June 11, 2010
